Sign Up to like & get
recommendations!
0
Published in 2025 at "Clinical Cancer Research"
DOI: 10.1158/1557-3265.sabcs24-p4-04-27
Abstract: Introduction: Antibody-Drug Conjugates (ADCs) have had tremendous impact on patient outcomes in breast cancer and are now second-line therapy for stage IV HER2 high expressing metastatic breast cancer as well as HER2 low expressing tumors.…
read more here.
Keywords:
multi payload;
payload conjugates;
her2 trop2;
conjugates targeting ... See more keywords